Detalhe da pesquisa
1.
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling.
Br J Cancer
; 129(2): 222-236, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081189
2.
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies.
Int J Mol Sci
; 24(4)2023 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36834641
3.
Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review.
Int J Mol Sci
; 23(7)2022 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35409355
4.
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer.
Int J Mol Sci
; 23(15)2022 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35955671
5.
Factors influencing diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in pancreatic and biliary tumors.
Scand J Gastroenterol
; 56(4): 498-504, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539716
6.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32164906
7.
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.
J Cell Physiol
; 235(11): 7900-7910, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943171
8.
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab.
Int J Cancer
; 146(9): 2531-2538, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396956
9.
Breast Cancer Is Associated with Increased HLA-DRB1*11:01 and HLA-DRB1*10:01 Allele Frequency in a Population of Patients from Central Italy.
Immunol Invest
; 49(5): 489-497, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32183601
10.
Noninferiority of three months versus six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice?
Int J Cancer
; 143(10): 2342-2350, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29873066
11.
Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain?
Pharmacol Res
; 131: 1-6, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29530602
12.
Oxidant stress as a major determinant of platelet activation in invasive breast cancer.
Int J Cancer
; 140(3): 696-704, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27784132
13.
Concordance of Blood-Based and Normal Tissue-Based Dihydropyrimidine Dehydrogenase (DPYD) Genotyping.
Oncologist
; 27(5): e420-e421, 2022 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325223
14.
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression.
Oncologist
; 21(9): 1041-9, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27388232
15.
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer.
Breast Cancer Res Treat
; 156(2): 301-10, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26975189
16.
Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
Int J Cancer
; 136(5): 1234-40, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25042739
17.
Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy.
Oncologist
; 19(5): 562-7, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24710308
18.
Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy.
Haematologica
; 99(10): 1638-44, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25085351
19.
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?
Cancers (Basel)
; 16(7)2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38610929
20.
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study.
J Clin Oncol
; 42(11): 1278-1287, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38181312